Overview
- Kennedy dismissed the 17-member Advisory Committee on Immunization Practices this month before installing eight replacements including vocal critics of mRNA vaccines as well as professionals who have served as paid witnesses in vaccine litigation.
- Sen. Bill Cassidy called for delaying the June 25-26 session until the panel is fully staffed with experts in microbiology, epidemiology or immunology alongside confirmation of a CDC director.
- Sen. Elizabeth Warren challenged several new appointees’ conflicts of interest in a letter to Kennedy, citing anti-vaccine publication revenue streams and prior paid testimony against vaccine manufacturers.
- The ACIP meeting will vote on recommendations for COVID-19, RSV as well as influenza vaccines, with a focus on thimerosal-containing formulations.
- With no Senate-confirmed CDC director in place, Secretary Kennedy retains final authority over ACIP recommendations, prompting experts to warn of reduced transparency as well as eroded public trust.